SCHEMBL4608500

SCHEMBL4608500

CS(=O)(=O)Nc1ccc(C2CCCC2C(N)=O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.53
KDM1A O60341 5/20 0.43
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 2/20 0.41
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
TSHR P16473 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
KMT2A Q03164 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 1/20 0.39
RECQL P46063 1/20 0.38
KEAP1 Q14145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605913 0.84 KDM1A (0.64) HRH3KDM1ALMNAMAOAMAOB
SCHEMBL4608502 0.80 KDM1A (0.50) HRH3KDM1AALDH1A1SMN1; SMN2HTT
SCHEMBL4606990 0.77 ALDH1A1 (0.49) KDM1AALDH1A1SLC6A2SLC6A4
SCHEMBL4608244 0.76 SIRT2 (0.40) HRH3SLC6A2SLC6A4
SCHEMBL4607805 0.75 GRIA4 (0.41) KDM1AALDH1A1MAOASLC6A2SLC6A4
SCHEMBL14141375 0.74 ALDH1A1 (0.47) HRH3KDM1AALDH1A1SMN1; SMN2HTT
SCHEMBL4371164 0.74 SLC6A4 (0.43) HRH3SLC6A2SLC6A4
SCHEMBL4608380 0.74 SIRT2 (0.52) KMT2A
SCHEMBL4371167 0.74 SLC6A4 (0.43) HRH3SLC6A2SLC6A4
SCHEMBL4605333 0.74 HRH3 (0.46) HRH3KDM1AMAOAMAOBSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed